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Abstract
Background As obesity becomes more prevalent, it presents a technical challenge for minimally invasive colorectal resection 
surgery. Various studies have examined the clinical outcomes of obese surgical patients. However, morbidly obese patients 
(BMI ≥ 35) are becoming increasingly more common. This study aims to investigate the short-term surgical outcomes of 
morbidly obese patients undergoing minimal-invasive colorectal surgery and compare them with both obese (30 ≤ BMI < 35) 
and non-obese patients (BMI < 30).
Methods Patients from three centres who received minimally invasive colorectal surgical resections between 2006 and 2016 
were identified from prospectively collected databases. The baseline characteristics and surgical outcomes of morbidly obese, 
obese and non-obese patients were analysed.
Results A total of 1386 patients were identified, 84 (6%) morbidly obese, 246 (18%) obese and 1056 (76%) non-obese. 
Patients’ baseline characteristics were similar for age, operating surgeon, surgical approach but diﬀered in terms of ASA 
grade and gender. There was no diﬀerence in conversion rate, length of stay, anastomotic leak rate and 30-day readmission, 
reoperation and mortality rates. Operation time and blood loss were diﬀerent across the 3 groups (morbidly obese vs obese 
vs non-obese: 185 vs 188 vs 170 min, p = 0.000; 20 vs 20 vs 10 ml, p = 0.003). In patients with malignant disease there was 
no diﬀerence in lymph node yield or R0 clearance. Univariate and multivariate linear regression analysis showed that for 
every one-unit increase in BMI operative time increases by roughly 2 min (univariate 2.243, 95% CI 1.524–2.962; multivari-
ate 2.295; 95% CI 1.554–3.036). Univariate and multivariate binary logistic regression analyses showed that BMI does not 
aﬀect conversion or morbidity and mortality.
Conclusions The increased technical diﬃculty encountered in obese and morbidly obese patients in minimally invasive 
colorectal surgery results in higher operative times and blood loss, although this is not clinically significant. However, 
conversion rate and post-operative short-term outcomes are similar between morbidly obese, obese and non-obese patients.
Keywords Minimally invasive · Laparoscopic · Colorectal surgery · Obese
Minimally invasive surgery (MIS) has become the new 
standard for colorectal diseases in the developed world, and 
its benefits such as shorter hospital stay, less post-operative 
pain, early mobilisation and improved cosmesis are well 
established [1–6]. These benefits are crucial for high-risk 
groups of patients such as the clinically obese who’s pres-
entation is clearly linked with several comorbidities such as 
diabetes mellitus and cardiovascular disease in addition to 
higher risks of suﬀering from surgical site infections and 
pulmonary embolisms [7]. Based on this, it is speculated 
that a less invasive approach to surgery would be optimal 
for this group of patients [8].
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Although obese patients have much to gain from a mini-
mally invasive approach to colorectal surgery, the increased 
amount of visceral fat encountered in obese patients 
increases the technical difficulty of surgery [8]. Obese 
patients often have a thickened and excessive omentum 
and mesentery which restricts access, distorts the surgical 
planes and can result in problematic bleeding [9]. Whether 
the increased technical diﬃculty encountered in this group 
of patients leads to higher conversion rates and worse short-
term outcomes is a subject of debate. For example, studies 
have examined the short-term outcomes of obese patients in 
laparoscopic colorectal surgery with many reporting inferior 
short-term outcomes in the obese [10–12] while others dem-
onstrating similar outcomes between obese and non-obese 
patients [13, 14].
An ageing population, austerity and lifestyle choices are 
causing a rise in obesity causing health and care challenges 
as well as high costs to the economy. In the US more than 
one-third of the population is reported to be obese and in the 
UK obesity prevalence has risen from 15% in 1993 to 26% 
in 2014 [15, 16]. In addition to this, morbidly obese patients 
are becoming increasingly more common. According to an 
English report by the Health and Social Care Information 
Centre (2016) on the Statistics on Obesity, Physical Activ-
ity and Diet [16], in England in 2014 2% of men and 4% 
of women had a BMI of 40 or higher. This number has tri-
pled over the last 25 years and presents a worrying picture, 
but in comparison, the USA reports 5% of the population is 
believed to be morbidly obese [15]. Therefore, the technical 
challenges discussed above for obese patients are magnified 
when considering minimally invasive surgery on morbidly 
obese patients where the risks encountered in this group 
of patients are even greater, due to the ever-greater amount 
of visceral fat encountered in the abdomen further restrict-
ing the space for manoeuvre during surgery and making it 
hard to define the surgical planes. Despite this, the surgical 
outcomes of this group of patients are poorly examined as 
most studies compare the outcomes of obese (BMI ≥ 30) vs 
non-obese patients (BMI < 30).
The study reported here aims to investigate the short-term 
surgical outcomes of morbidly obese (BMI ≥ 35) patients 
undergoing minimally invasive colorectal resection surgery 
and compare them to those of obese (30 ≤ BMI < 35) and 
non-obese (BMI < 30) patients. This study presents the big-
gest European series examining morbidly obese patients 
receiving minimally invasive colorectal resection surgery.
Materials and methods
Consecutive patients from three centres, two from the UK 
and one from Portugal, who received minimally invasive 
colorectal surgical resections between 2006 and 2016 
were identified from prospectively collected databases. All 
patients whose BMI was reported were included in the study. 
Patients were categorised as morbidly obese (BMI ≥ 35), 
obese (30 ≤ BMI < 35) and non-obese (BMI < 30) in accord-
ance with the NIH conference [17].
Patients were included in the study irrespective of indica-
tion for surgery and obesity or morbid obesity was not con-
sidered a contraindication for minimally invasive surgery. 
All cancer patients were discussed in the multidisciplinary 
team meeting. Surgery was laparoscopic or robotic, with 
the robotic approach being preferred for all rectal surgery 
since the acquisition of the robot in each unit. Applied sur-
gical modality was based on surgeon preference and equip-
ment availability. Informed consent was obtained from all 
patients prior to inclusion to this study. The requirements for 
anonymization of personal dataset by the Data Protection 
Act 1998 were satisfied. According to the Health Research 
Authority (HRA), this study was not classified to need their 
approval as it is an audit.
Patients included in the study had surgery performed 
by three colorectal surgeons, one surgeon in each centre. 
Data collection began when the surgeons participating in 
this study started working in their respective units, between 
2006 and 2012 for the UK centres and 2013 for the Portu-
guese centre. All surgeons applied a modular, standardised 
previously described approach to surgery [18–20].
Post-operative care was standardised, with patients enter-
ing a routine enhanced recovery programme based on the 
one described by Kehlet and Wilmore [21]. Patients were 
discharged home when their condition was assessed as meet-
ing set criteria for discharge.
Data collection and outcome assessment
All data were collected from prospectively collated data-
bases. The baseline characteristics and surgical outcomes 
of morbidly obese, obese and non-obese patients were ana-
lysed. Baseline characteristics analysed were age, gender, 
ASA grade, diagnosis (malignant vs benign), mode (elective 
vs emergency), surgical approach (laparoscopic vs robotic), 
operating surgeon, operation performed and T stage (for 
malignant disease). Perioperative data included operative 
time, estimated blood loss and conversion to open (defined 
as any incision needed to either mobilise the colon or rectum 
or ligate the vessels). Post-operative clinical data examined 
included length of stay, 30-day readmission, 30-day reopera-
tion, 30-day mortality and anastomotic leak. For malignant 
disease cases lymph node yield and circumferential resec-
tion margin (CRM) clearance were examined. Two subgroup 
analyses were performed. Morbidly obese patients with a 
BMI ≥ 40 were compared with patients whose BMI was 
≥ 35 and < 40. Moreover, subgroup analyses of patients 
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receiving right colonic, left colonic and rectal resections 
was performed.
Statistical analysis
Data were analysed using IBM SPSS version 22 (SPSS Inc., 
Chicago, IL, USA). Non-parametric data were expressed as 
median with interquartile range and parametric data as mean 
with standard deviation. Baseline demographic and clinical 
characteristics were compared using χ2 test for categorical 
variables, Kruskal–Wallis test for non-parametric continuous 
variables and one-way ANOVA for parametric continuous 
variables. P values of < 0.05 were considered statistically 
significant. Univariate binary logistic regression analysis 
was performed to assess whether BMI aﬀected conversion to 
open or morbidity and mortality, with morbidity and mortal-
ity defined as the presence of any of the following outcomes: 
30-day reoperation, 30-day readmission, anastomotic leak 
and 30-day mortality. Following this, a multivariate model 
was applied were BMI was adjusted for all clinically relevant 
variables. Finally, a univariate and multivariate linear regres-
sion model was applied to investigate the eﬀect of BMI on 
operative time. Since both BMI and operation time were 
non-parametric, Spearman’s rank correlation was calculated 
to evaluate the correlation.
Results
A total of 1386 patients underwent minimally invasive colo-
rectal resection surgery by a surgeon from each study site. 
Of those, 84 (6%) were morbidly obese, 246 (18%) obese 
and 1056 (76%) non-obese.
Baseline characteristics
The baseline characteristics of the three groups are summa-
rised in Table 1. Patient baseline characteristics were similar 
for age, diagnosis, operating surgeon, surgical approach and 
T stage but diﬀered in terms of ASA grade, gender and mode 
of surgery.
As expected ASA grade was worse in the morbidly 
obese group. There were more female patients in the mor-
bidly obese group and less in the obese group compared to 
the non-obese group (female patients in morbidly obese vs 
obese vs non-obese: 58.3% vs 38.6% vs 46.7%; p = 0.005). 
The obese group had the least amount of patients receiving 
emergency surgery and the non-obese group the most (mor-
bidly obese vs obese vs non-obese: 2.4% vs 0.8% vs 3.9%; 
p = 0.045). The operative procedures performed across the 
3 groups are summarised in Table 2.
Perioperative characteristics and outcomes
The perioperative characteristics of the three groups are 
summarised in Table 3. Operation time and blood loss were 
diﬀerent across the three cohorts (morbidly obese vs obese 
vs non-obese: median operation time 185 vs 188 vs 170 min, 
p = 0.000; median estimated blood loss 20 vs 20 vs 10 ml, 
p = 0.003). Conversion rate was similar across the three 
groups with an overall conversion rate of 1.2% (p = 0.251).
Post-operative clinical and pathological outcomes
There were no differences in any of the post-operative 
clinical outcomes (length of stay, 30-day readmission rate, 
30-day reoperation rate, anastomotic leak rate, 30-day mor-
tality rate) or pathological outcomes (lymph node yield and 
CRM clearance) between the three cohorts as summarised 
in Table 4.
Logistic and linear regression analysis
Univariate logistic regression analysis showed that BMI 
did not aﬀect conversion to open for the participants in this 
study. This was still the case in multivariate analysis when 
other clinically relevant factors were adjusted for (age, ASA 
grade, mode of surgery, diagnosis). Findings are summa-
rised in Table 5. Furthermore, univariate logistic regression 
analysis (Table 6) showed that BMI did not aﬀect morbidity 
and mortality. This was still the case in multivariate analysis 
when other clinically relevant factors were adjusted for (age, 
ASA grade, mode of surgery, diagnosis).
There was however, a weak but significant corre-
lation between BMI and operative time (Spearman’s 
ρ = 0.182; p = 0.000). Univariate linear regression analy-
sis showed that for every one-unit increase in BMI opera-
tive time increases by roughly 2 min (b = 2.243, 95% CI 
1.524–2.962;  p= 0.000). This was still the case in multi-
variate analysis when other clinically relevant factors were 
considered (ASA grade, mode of surgery) (b = 2.295, 95% 
CI 1.554–3.036; p = 0.000). Findings are summarised in 
Table 7. Figure 1 represents the scatter plot of BMI against 
operative time.
Subgroup analyses
Patients with 35 ≤ BMI < 40 vs BMI ≥ 40
There were 64 patients with a BMI between 35 and 40 and 
20 with a BMI equal or greater than 40. Patients with a 
BMI ≥ 40 were younger (66 vs 59.5; p = 0.044). There were 
no other significant diﬀerences in any of the baseline char-
acteristics or short-term surgical outcomes between the 
two groups. Operation time appeared to be higher in the 
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Table 1  Baseline characteristics
Statistically significant values are given in bold
a Kruskal–Wallis Test
b Chi-square
Non-obese (n = 1056) Obese
(n = 246)
Morbidly obese
(n = 84)
p value
Median BMI 25 (22.7–27) 31 (30–32) 36 (35.1–39) 0.000a
Median age 68 (58–77) 65 (58.2–73.9) 65 (58-72.2) 0.056a
Gender
 Male 563 (53.3%) 151 (61.4%) 35 (41.7%) 0.005b
 Female 493 (46.7%) 95 (38.6%) 49 (58.3%)
ASA grade
 I 159 (15.4%) 27 (11.1%) 3 (3.7%) 0.000b
 II 680 (65.8%) 164 (67.5%) 41 (50%)
 III 191 (18.5%) 51 (21%) 37 (45.1%)
 IV 4 (0.4%) 1 (0.4%) 1 (1.2%)
Diagnosis
 Malignant 784 (74.2%) 193 (78.5%) 66 (78.6%) 0.297b
 Benign 272 (25.8%) 53 (21.5%) 18 (21.4%)
Mode of surgery
 Elective 1015 (96.1%) 244 (99.2%) 82 (97.6%) 0.045b
 Emergency 41 (3.9%) 2 (0.8%) 2 (2.4%)
Surgical approach
 Laparoscopic 979 (92.7%) 226 (91.9%) 81 (96.4%) 0.371b
 Robotic 77 (7.3%) 20 (8.1%) 3 (3.6%)
Operating Surgeon
 A 778 (73.7%) 181 (73.6%) 64 (76.2%) 0.927b
 B 30 (2.8%) 7 (2.8%) 1 (1.2%)
 C 248 (23.5%) 58 (23.6%) 19 (22.6%)
T stage
 0 29 (3.8%) 9 (4.7%) 2 (3%) 0.116b
 1 70 (9.1%) 24 (12.6%) 6 (9%)
 2 170 (22.1%) 43 (22.6%) 24 (35.8%)
 3 397 (51.6%) 95 (50%) 32 (47.8%)
 4 104 (13.5%) 19 (10%) 3 (4.5%)
Table 2  Operative procedures Non-obese (n = 1056) Obese (n = 246) Morbidly 
obese 
(n = 84)
Right hemicolectomy 280 (26.5%) 41 (16.7%) 16 (19%)
Extended right hemicolectomy 48 (4.5%) 8 (3.3%) 3 (3.6%)
Left hemicolectomy 24 (2.3%) 6 (2.4%) 4 (4.8%)
Sigmoid colectomy 34 (3.2%) 16 (6.5%) 4 (4.8%)
Anterior resection 467 (44.2%) 136 (55.3%) 40 (47.6%)
Abdominoperineal excision 41 (3.9%) 11 (4.5%) 10 (11.9%)
Hartman’s procedure 21 (2%) 4 (1.6%) 2 (2.4%)
other 141 (13.4%) 24 (9.8%) 5 (6%)
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BMI ≥ 40 group but this was not statistically significant (180 
vs 194 min; p = 0.142).
Right colonic, left colonic and rectal resections
There was a total of 396 patients that received right colon, 
88 left colon and 732 rectal resections. The remaining 
patients received a combination of subtotal colectomies, 
proctocolectomies and panproctocolectomies.
For the right colonic resections, the results were similar 
to those of the overall cohort, although operation time and 
blood loss did not reach statistical significance (morbidly 
obese vs obese vs non-obese: median operation time 125 
vs 125 vs 115 min, p = 0.101; median estimated blood loss 
20 vs 20 vs 10 ml, p = 0.065). There were no observed 
Table 3  Perioperative characteristics and outcomes
Statistically significant values are given in bold
a Kruskal–Wallis Test
b Chi-square
Non-obese (n = 1056) Obese (n = 246) Morbidly obese (n = 84) p value
Median operative time (min) 170 (125–210) 188 (145–240) 185 (145–210) 0.000a
Median estimated blood loss (ml) 10 (0–20) 20 (0–45) 20 (10–50) 0.003a
Conversion to open 11 (1%) 5 (2%) 0 0.251b
Table 4  Post-operative clinical 
and pathological outcomes
a Kruskal–Wallis Test
c Chi-square
Non-obese (n = 1056) Obese (n = 246) Morbidly obese (n = 84) p value
Median length of stay (days) 4 (3–7) 5 (3–7) 4 (3–7) 0.454a
30-day readmission 115 (10.9%) 28 (11.4%) 14 (16.7%) 0.274b
30-day reoperation 31 (2.9%) 5 (2%) 4 (4.8%) 0.427b
30-day mortality 5 (0.5%) 0 0 0.454b
Anastomotic leak 14 (1.5%) 3 (1.3%) 2 (2.8%) 0.663b
Median lymph node yield 16.5 (12–23) 16 (11–23) 18 (14–22.75) 0.267a
R0 clearance 743 (94.8%) 190 (98.4%) 66 (100%) 0.079b
Table 5  Univariate and 
multivariate logistic regression 
for conversion
OR odds ratio, CI confidence interval
Univariate Multivariate
OR 95% CI p value OR 95% CI p value
BMI 1.016 0.927–1.114 0.731 1.029 0.935–1.133 0.556
Age 1.006 0.973–1.040 0.714 1.023 0.985–1.063 0.241
ASA grade 0.965 0.422–2.205 0.933 0.844 0.357–1.996 0.700
Mode of surgery (emergency) 0.498 0.064–3.852 0.504 0.483 0.059–3.916 0.495
Diagnosis (malignant) 1.839 0.663–5.098 0.241 2.592 0.818–8.211 0.105
Table 6  Univariate and 
multivariate logistic regression 
for morbidity and mortality
OR odds ratio, CI confidence interval
Univariate Multivariate
OR 95% CI p value OR 95% CI p value
BMI 1.011 0.981–1.041 0.492 1.005 0.975–1.037 0.738
Age 0.994 0.985–1.004 0.233 0.994 0.982–1.007 0.356
ASA grade 1.222 0.938 – 1.590 0.137 1.298 0.975–1.728 0.074
Mode of surgery (emergency) 0.719 0.330–1.569 0.408 0.777 0.349–1.732 0.537
Diagnosis (malignant) 1.302 0.925–1.302 0.130 1.197 0.789–1.815 0.398
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diﬀerences in terms of baseline characteristics or short-
term surgical outcomes between the three cohorts in left 
colonic resections.
In rectal resections, results reflected again those of the 
overall cohort results (ASA higher with increasing BMI, 
operation time and blood loss higher in obese and mor-
bidly obese groups) and there were no diﬀerences in any of 
the short-term post-operative outcomes between the three 
groups with the exception of readmission rate, which was 
higher in the morbidly obese group (non-obese vs obese vs 
morbidly obese: 10.2, 9.9, and 23.1%; p = 0.016).
Discussion
Morbid obesity is becoming increasingly more common 
and the surgical outcomes of this group of patients war-
rant further investigation [15, 16]. In this study, we have 
found that the increased technical diﬃculty encountered 
in obese and morbidly obese patients in minimally inva-
sive colorectal surgery results in higher operative times 
and blood loss. However, conversion rate, length of stay, 
30-day readmission, 30-day reoperation, anastomotic leak 
and 30-day mortality rates were similar between non-
obese, obese and morbidly obese patients. In addition, our 
results demonstrate that in cancer patients there were no 
diﬀerences in lymph node yield and CRM (R0) clearance 
Fig. 1  Scatter plot of BMI 
against operative time
Table 7  Univariate and multivariate linear regression for operative time
Statistically significant values are given in bold
CI confidence interval
Correlation for BMI: Spearman’s ρ = 0.182; p = 0.000
Univariate Multivariate
Estimate (beta) 95% CI p value Estimate (beta) 95% CI p value
BMI 2.243 1.524 to 2.962 0.000 2.295 1.554 to 3.036 0.000
ASA grade − 4.220 − 10.467 to 2.027 0.185 − 6.323 − 12.540 to − 0.106 0.046
Mode of surgery 
(emergency)
− 17.671 − 38.817 to 3.474 0.101 − 12.939 − 34.269 to 8.390 0.234
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rates between the three cohorts. Furthermore, BMI was not 
found to aﬀect conversion rate or morbidity and mortality 
on logistic regression analysis. These findings strengthen 
the argument that by standardising operative technique 
and post-operative care minimally invasive surgery for 
the morbidly obese and obese is safe, feasible and does 
not result in higher surgical morbidity.
In our study we found that operative time and estimated 
blood loss were higher in the obese and morbidly obese 
groups. However, the operative time and blood loss of the 
obese and morbidly obese groups were similar. This is dif-
ferent to what we anticipated, since the increasing technical 
diﬃculty associated with operating on the morbidly obese 
patients was expected to result in even longer operative times 
and higher blood loss. Furthermore, it should be noted that 
although statistically significant, the diﬀerences in operative 
time and blood loss are not clinically significant. Patients in 
the obese and morbidly obese groups took an extra 15 min 
to operate on and had an additional 10 mls of blood loss. 
Considering the median operative time for the non-obese 
was over 3 h, the longer operative time and higher blood loss 
encountered in the obese and morbidly obese are unlikely 
to significantly aﬀect the patient’s clinical outcomes as our 
results infers.
Our results are in accordance with a recently published 
meta-analysis [10] examining the outcomes of obese vs non-
obese laparoscopic colorectal surgery patients. This study 
combined the data of 13 and 6 studies for operative time and 
blood loss respectively and found that both parameters were 
higher in the obese group, by an average of 13 min and 34 
mls, respectively. The operative time and blood loss of obese 
vs non-obese patients receiving laparoscopic colorectal sur-
gery was also examined in a recently published systematic 
review including 30 studies [13]. In this review it is clear 
that there is great variability in reported outcomes. Regard-
ing operative time 18 studies reported longer operative times 
in the obese vs 12 that did not. In terms of estimated blood 
loss, 8 studies reported higher blood loss in the obese and 8 
found no diﬀerence between the two groups. The diﬀerences 
in reported outcomes are probably multifactorial. First of all, 
studies failing to demonstrate a diﬀerence could be doing so 
due to a type 2 error. This is because the actual diﬀerences 
are small and therefore a large sample size is required to 
demonstrate a statistically significant diﬀerence in outcomes. 
A second reason might be variability in surgical practise. 
The operative technique and experience of some surgeons 
might be better adapted to cope with the increased technical 
diﬃculties of obese patients, therefore making less likely to 
demonstrate any diﬀerences in surgical outcomes.
In our study, we found that BMI was as independent factor 
for operative time as demonstrated in linear regression anal-
ysis. Although the actual correlation was weak (ρ = 0.182), 
it was statistically significant and linear regression analysis 
showed that for every increase in one unit of BMI operative 
time increased by roughly 2 min. We are not the first study to 
demonstrate that BMI is an independent predicting factor for 
operative time, with three previously published studies dem-
onstrating similar results [22–24], one of which compared 
the operative times of morbidly obese (BMI ≥ 35) patients 
to non-obese patients [22].
Apart from operative time and blood loss, there were no 
statistically significant diﬀerences in short-term surgical out-
comes between the three groups. This is opposite to what 
one might expect, considering again the increased technical 
diﬃculties encountered when operating on obese and even 
more so on morbidly obese patients. Multiple previous stud-
ies (including systematic reviews and meta-analysis) have 
shown that obesity is associated with a higher conversion 
rate, anastomotic leak rate, increased post-operative mor-
bidity and a lower lymph node yield in minimally invasive 
surgery [10–12, 25]. However, several studies have reported 
similar short-term surgical outcomes between obese and 
non-obese patients [9, 13, 14]. Just as for operative time and 
blood loss, the reasons behind this are probably multifacto-
rial. Variability in surgical practice, surgeon experience and 
centre volume can all eﬀect surgical outcomes. Furthermore, 
small sample sizes and small outcome diﬀerences reduce the 
prospect of demonstrating a statistically significant diﬀer-
ence. We believe that by standardising operative technique 
and breaking down surgical procedures in digestible mod-
ules we enhance reproducibility of results and facilitate sur-
gical training. This way, surgical outcomes are fairly similar, 
regardless of perioperative conditions. This could account 
for the similar short-term surgical outcomes in our patients, 
regardless of their obesity level.
Only a handful of studies have specifically examined the 
morbidly obese [14, 25–27], most of them using a cut-oﬀ 
of BMI ≥ 40 [14, 25, 26]. Hussan et al. examined 85,300 
discharges of colorectal cancer surgery patients from the 
US 2012 National Inpatient Sample and found that morbid 
obesity was associated with a higher prevalence of periop-
erative comorbidities, surgical complications, conversions to 
open, perioperative mortality and prolonged length of stay 
[25]. However, it should be noted that in this study 70% of 
patients received open surgery. In contrast, Khoury et al. 
[14] specifically examined the feasibility of laparoscopic 
surgery in the morbidly obese. In this study, there was no 
statistical diﬀerence in any surgical outcomes between the 
morbidly obese and non-obese (36 vs 36 patients) apart from 
skin incision length. However, the authors have reported a 
trend towards worse short-term outcomes in the morbidly 
obese group. This could be suggested with some of our 
results. Readmission, reoperation and anastomotic leak rates 
appear higher in the morbidly obese group when compared 
to the obese and non-obese groups (Table 4). Nonetheless, 
these diﬀerences are small and not statistically significant. In 
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addition, when examining whether BMI aﬀected conversion 
rate or morbidity and mortality in a logistic regression model 
no association was demonstrated.
A recently published American study by Champagne 
et al. examined the outcomes of obese patients having lapa-
roscopic colectomies based on the degree of obesity [26]. 
In this study, obese patients were divided in three groups 
(obese, morbidly obese and super-obese) and had their out-
comes evaluated. This manuscript concluded that increas-
ing obesity severity correlated with worse perioperative out-
comes. However, the majority of the short-term outcomes 
presented (operative time, conversion rate, post-operative 
morbidity and length of stay) are similar between the obese 
and morbidly obese groups, with these outcomes only 
worsening in the super-obese group (BMI ≥ 50). In terms 
of the morbidly obese, their results are similar to our find-
ings, demonstrating no real diﬀerences between morbidly 
obese and obese patients. The worse short-term outcomes 
presented in the super-obese group could be secondary to 
the greatly increased visceral adiposity and abdominal wall 
size, further adding to the technical complexity of the opera-
tion. In our study population evaluation of the super-obese 
surgical outcomes was prohibited due to the small sample 
size (n = 4).
Subgroup analysis of the data according to right colon, 
left colon and rectal resections widely demonstrated similar 
results to those of the overall cohort. However, it should be 
noted that readmission rate was higher in the morbidly obese 
group for rectal resections, while similar between the obese 
and non-obese groups. It might be that in patients with mor-
bid obesity (BMI ≥ 35) rectal resection presents a technical 
challenge of even tighter pelvic space occupied by a rather 
large mesorectum which may result in even greater intra-
operative diﬃculty, leading to higher morbidity reflected by 
a higher readmission rate. However, this is an isolated posi-
tive finding that was not reconfirmed in logistic regression 
analysis (data not shown).
The main strengths of this study are its large sample size, 
the fact that data were collected from three centres from two 
diﬀerent countries and the fact that all three participating 
surgeons follow the same modular standardised operative 
techniques. However, as with all research there are specific 
limitations that should be duly recognised and acknowl-
edged. Despite collecting data from prospectively collated 
databases, the study design was retrospective in nature. 
However, collecting data from prospectively maintained 
databases minimises observation bias and by including all 
consecutive patients’ selection bias is minimised. Secondly, 
we have defined morbid obesity as BMI ≥ 35 in accordance 
with the NIH conference [17]. However, many studies exam-
ining morbid obesity use BMI 40 as a cut-oﬀ. Although a 
BMI ≥ 40 would better allow us to evaluate the eﬀect of an 
ever-increasing BMI on surgical outcomes, we only had a 
small number of patients with BMI ≥ 40 (n = 20). A sub-
group analysis of patients with 35 ≤ BMI < 40 vs BMI ≥ 40 
showed no significant diﬀerences between the two groups, 
but results should be taken with caution due to the small 
sample size. A further limitation in our study is that there 
are diﬀerences in the baseline characteristics in terms of 
ASA grade, mode of surgery and gender between the three 
examined cohorts. ASA grade increased across the obesity 
categories as one would expect, but the diﬀerences in gen-
der and mode of surgery appear random. Nevertheless, the 
diﬀerences in gender and mode of surgery are relatively 
small. Moreover, ASA grade and mode of surgery have been 
accounted for in the multivariate logistic regression analysis.
In summary, our study’s findings show that minimally 
invasive colorectal surgery is safe and feasible regardless of 
BMI when operative technique and perioperative care are 
standardised. The increased operative time and blood loss 
observed in the obese and morbidly obese are of no clinical 
significance and have not been proved to aﬀect the rest of 
the short-term surgical outcomes. Therefore, this group of 
patients is likely to benefit from the advantages oﬀered by 
minimally invasive surgery. Larger scale multi-centre obser-
vational studies are required to determine the outcomes of 
morbidly obese patients receiving minimally invasive colo-
rectal surgery.
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